Amgen’s new cancer drug, targeting the common mutation KRAS, beat chemotherapy in a study, but the results leave room for rivals with drugs in the works
New data from the first of a new type of cancer drug suggest its benefits and limitations, while leaving room for other candidates seeking to enter the lucrative market.
beat out a common chemotherapy in a late-stage study, helping patients survive without their tumors getting worse, but failed to prove that it reduced overall deaths, the company said.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
'We're going to cure cancer': Biden channels JFK on 60th anniversary of his moonshot speechBiden and health advisors are touting a new study showing promise in screening for multiple cancers, as well as a plan to increase funding for cancer research and treatments.
Weiterlesen »
In a nod to JFK, Biden pushing ‘moonshot’ to fight cancerPresident Biden is traveling to Boston on Monday to highlight a new federally backed study that seeks to validate using blood tests to screen against multiple cancers.
Weiterlesen »
Tiny 'Drug Factory' Implants Can Eradicate Tumors in Mice in Just DaysScientists have managed to stop advanced-stage cancers in mice through the use of implanted 'drug factories' – and the new type of treatment only takes a few days to become effective.
Weiterlesen »
California is using fewer antipsychotic drugs on its abused and neglected children. What’s behind the dramatic decline?Child advocates encouraged by a new study that found a 58% decline in antipsychotic drugs prescribed to California foster kids over the last decade, but concerns remain over how the state’s f…
Weiterlesen »
Young People Are Getting Way More Cancer Than Old People DidEarly-onset cancer is an increasing threat to the global population, according to a new report. Early-onset cancer may be a new epidemic.
Weiterlesen »